Last updated: February 3, 2024
Sponsor: Fundación EPIC
Overall Status: Completed
Phase
N/A
Condition
Atherosclerosis
Heart Disease
Coronary Artery Disease
Treatment
Naviscore
Clinical Study ID
NCT05706805
NAVISCORE PMCF Study
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patient treated with Naviscore according to routine hospital practice and followinginstructions for use
- Informed consent signed
Exclusion
Exclusion Criteria:
• Not meet inclusion criteria
Study Design
Total Participants: 54
Treatment Group(s): 1
Primary Treatment: Naviscore
Phase:
Study Start date:
January 31, 2023
Estimated Completion Date:
September 27, 2023
Study Description
Connect with a study center
Hospital Clinic de Barcelona
Barcelona, 08036
SpainSite Not Available
Hospital Universitari Vall D'Hebron
Barcelona, 08035
SpainSite Not Available
Hospital Universitario de Cáceres
Cáceres, 10003
SpainSite Not Available
Hospital Universitario Juan Ramon Jimenez
Huelva, 21005
SpainSite Not Available
Hospital Universitario de Leon
León, 24008
SpainSite Not Available
Hospital Universitario Lucus Agusti
Lugo, 27003
SpainSite Not Available
Hospital Regional Universitario Carlos Haya
Málaga, 29010
SpainSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.